AN IMMUNOHISTOCHEMICAL STUDY OF THE BREAST USING ANTIBODIES TO BASAL AND LUMINAL KERATINS, ALPHA-SMOOTH MUSCLE ACTIN, VIMENTIN, COLLAGEN-IV AND LAMININ .2. EPITHELIOSIS AND DUCTAL CARCINOMA INSITU

被引:75
作者
BOCKER, W [1 ]
BIER, B [1 ]
FREYTAG, G [1 ]
BROMMELKAMP, B [1 ]
JARASCH, ED [1 ]
EDEL, G [1 ]
DOCKHORNDWORNICZAK, B [1 ]
SCHMID, KW [1 ]
机构
[1] UNIV HEIDELBERG,GERMAN CANC RES CTR,INST CELL & TUMOR BIOL,W-6900 HEIDELBERG,GERMANY
关键词
HYPERPLASTIC BREAST LESIONS; ANTIKERATIN ANTIBODY; ANTISMOOTH MUSCLE ACTIN ANTIBODY; ANTIVIMENTIN ANTIBODY; ANTICOLLAGEN-IV ANTIBODY; IMMUNOHISTOLOGY;
D O I
10.1007/BF01660979
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
A detailed immunohistochemical study has been carried out on 63 breast lesions with epitheliosis, ductal carcinoma in situ and clinging carcinoma (lobular cancerization), using antibodies directed against keratins 5/14 and 14, 15, 16, 18, 19, vimentin, smooth muscle actin, collagen IV and laminin. The results have shown that epitheliosis on the one hand and ductal in situ and clinging carcinoma on the other are immunohistochemically different epithelial lesions. Epitheliosis appears to be epithelial hyperplasia with keratin 5/14 and keratin 14, 15, 16, 18, 19-positive cells. Compared to epitheliotic cells tumor cells of clinging carcinoma, lobular cancerization and ductal carcinoma in situ expressed only luminal keratins 14, 15, 16, 18, 19 in 85% of the cases studied; whereas in 15% there was a basal keratin expression. From our results we conclude that the clinging carcinoma (lobular cancerization) represents the initial morphological step in the. development of ductal carcinoma in situ and thus may be interpreted as a minimal ductal neoplasia. With the immunohistochemical demonstration of basal and luminal keratins it may be possible in individual cases to differentiate between benign and malignant in situ lesions of the breast.
引用
收藏
页码:323 / 330
页数:8
相关论文
共 37 条
  • [1] [Anonymous], 1987, DIAGNOSTIC HISTOPATH
  • [2] [Anonymous], 1979, PROBLEMS BREAST PATH
  • [3] BASSLER R, 1978, SPEZIELLE PATHOLOGIE, V2
  • [4] BLACK MM, 1980, PATHOL RES PRACT, V166, P491, DOI 10.1016/S0344-0338(80)80247-0
  • [5] AN IMMUNOHISTOCHEMICAL STUDY OF THE BREAST USING ANTIBODIES TO BASAL AND LUMINAL KERATINS, ALPHA-SMOOTH MUSCLE ACTIN, VIMENTIN, COLLAGEN-IV AND LAMININ .1. NORMAL BREAST AND BENIGN PROLIFERATIVE LESIONS
    BOCKER, W
    BIER, B
    FREYTAG, G
    BROMMELKAMP, B
    JARASCH, ED
    EDEL, G
    DOCKHORNDWORNICZAK, B
    SCHMID, KW
    [J]. VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1992, 421 (04) : 315 - 322
  • [6] BOCKER W, 1986, PATHOLOGY NEOPLASTIC, P72
  • [7] Carter D., 1990, INTERPRETATION BREAS
  • [8] IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES)
    CORDELL, JL
    FALINI, B
    ERBER, WN
    GHOSH, AK
    ABDULAZIZ, Z
    MACDONALD, S
    PULFORD, KAF
    STEIN, H
    MASON, DY
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) : 219 - 229
  • [9] RISK-FACTORS FOR BREAST-CANCER IN WOMEN WITH PROLIFERATIVE BREAST DISEASE
    DUPONT, WD
    PAGE, DL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (03) : 146 - 151
  • [10] EUSEBI V, 1989, SEMIN DIAGN PATHOL, V6, P165